Work with us
Fund the change: drive healthier, happier long lives
For nearly 30 years, ILC has been at the forefront of global policy on ageing – connecting evidence to solutions and solutions to power.
Our five missions
- See longevity as an opportunity: Keeping people healthy and financially secure as they age builds longer, more productive lives and stronger economies
- Make prevention pay: We champion solutions that improve health and deliver lasting economic returns
- Champion intergenerational fairness: We focus on opportunity and wellbeing for every generation, with sustainable public services. Intergenerational fairness, not generational war
- Break down silos: We unite government, business and civil society so ageing sits at the heart of strategy, not on the margins
- Think global, act local: We turn global insight into local action and put ageing at the centre of G20, G7 and IMF economic agendas
Why ILC – and why now?
ILC works across health, finance, work and community simultaneously – which means we understand how demographic change in one area connects to the rest. We carry ideas from local communities to the world stage, as comfortable talking to individuals on the high street as negotiating in international forums.
In the past year alone, our work has reached the pages of the Financial Times, informed HM Treasury and international finance ministries, and convened senior policymakers around the global longevity dividend.
Who backs our work?
- Businesses in financial services, housing, care and pharmaceuticals
- Charitable trusts and foundations funding ambitious, long-term work on demography, health, prevention and financial security
- Universities seeking a partner with a proven record of turning research into real-world impact
- Public sector bodies commissioning evidence on healthy ageing, work, housing and resilience
- Individuals who share our vision and want to help drive it
Our Supporters include
Some funders support a single project; others build long-term strategic partnerships with us.
| Supporter | Contribution |
| Hallmark Foundation | Five years of support from local to global – including our Healthy Ageing and Prevention Index and UK Better Lives Index |
| Pfizer, GSK, MSD, Sanofi & Seqirus | Global work on preventative health and the Healthy Ageing and Prevention Index |
| UK FCO & Department for Business and Trade | Joint work in Japan, China, Portugal, the EU and North America on longevity and economic growth |
| M&G | Research strengthening the intergenerational contract |
| Greater Manchester Combined Authority | Solutions helping the night-time economy adapt to longer lives |
| Amgen & Gilead | Analysis on ageing in low- and middle-income countries; research and convening on HIV and older adults |
Get in touch
To discuss funding our programmes or driving our agenda forward, contact ILC's Deputy Chief Executive, Ben Franklin, via the button below
CASE STUDY
Maximising the longevity dividend – reframing ageing as opportunity
Maximising the Longevity Dividend challenged the tired "ticking time bomb" narrative and replaced it with numbers that couldn’t be ignored:
- Older consumers already account for over half of UK consumer spending – £319 billion in 2018, rising towards £550 billion by 2040.
- Supporting people aged 75+ to spend like their younger peers could add up to 8% annually to GDP by 2040.
- Launched alongside the G20 Finance Ministers' meeting and adapted for the US, Italy and Canada, the work has measurably shifted how businesses and policymakers talk about longevity.
Case study
Life-course immunisation – from UK report to global policy
Over a decade, our prevention and life-course immunisation programme has made the case that keeping people healthy as they age is an investment, not a cost. The results speak for themselves:
- Helped secure a G20 ministerial commitment to prevention in Japan
- Shaped the WHO Immunization Agenda 2030– which added a dedicated chapter on life-course and adult immunisation
- Saw an ILC recommendation adopted into UK guidelines
- Our report No Health, No Wealth, taken directly to G7 and G20 finance meetings, sharpened the economic argument.
